STOCK TITAN

ASP Isotopes (ASPI) Rule 144 Notice for Insider Sale of 8,438 Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 Notice: The filing discloses a proposed sale of 8,438 shares of common stock of ASP Isotopes Inc. (ASPI) with an aggregate market value of $69,191.60. The securities are to be sold through Independent Trading Group (ITG) Inc., and the sale is identified for 09/08/2025 on the NASDAQ. The filer acquired 300,000 shares on 09/06/2024 as a restricted stock award from the issuer and the acquisition was paid as equity compensation on the same date. The form states there were no sales by the filer in the prior three months and includes the standard signature representation regarding material nonpublic information.

Positive

  • Transparent disclosure of planned sale details including number of shares, aggregate market value, broker, and planned sale date
  • Acquisition source disclosed: shares were acquired as a restricted stock award and paid via equity compensation on 09/06/2024
  • No sales in prior three months reported, indicating this filing is the first recent disposition by the filer

Negative

  • None.

Insights

TL;DR: Small insider sale disclosed: 8,438 shares (~$69k) scheduled for sale from restricted stock awarded on 09/06/2024.

The filing documents a routine Rule 144 notice for a proposed disposition of shares originally granted as restricted stock. The shares were acquired as equity compensation and the planned sale amount represents approximately 0.0092% of the reported outstanding shares (8,438 of 91,913,109), indicating the sale is immaterial to overall capitalization. The use of a broker and the filing itself reflects compliance with resale rules for restricted securities.

TL;DR: Compliance-focused disclosure with no prior sales reported; transaction appears procedural rather than strategic.

The notice includes the required attestation about no undisclosed material information and shows no sales in the prior three months, which supports standard insider reporting practices. The acquisition date and nature (restricted stock award) are explicitly stated, and the planned sale date and broker are provided, offering transparency into execution logistics. No additional governance issues or plan adoption details are supplied in the filing.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ASPI Form 144 disclose about the planned sale?

The notice discloses a proposed sale of 8,438 shares of ASPI common stock valued at $69,191.60, to be sold on 09/08/2025 on the NASDAQ through Independent Trading Group (ITG) Inc.

When and how were the shares being sold originally acquired according to the filing?

The filer acquired 300,000 shares on 09/06/2024 as a Restricted Stock Award from the issuer, paid as equity compensation on the same date.

Does the filing report any sales of ASPI securities by the filer in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What representation does the filer make regarding material nonpublic information?

By signing the notice, the filer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Which broker is named for the sale and where is it located?

The broker listed is Independent Trading Group (ITG) Inc. with an address at 33 Yonge Street, Suite 420, Toronto.
ASP Isotopes

NASDAQ:ASPI

View ASPI Stock Overview

ASPI Rankings

ASPI Latest News

ASPI Latest SEC Filings

ASPI Stock Data

527.34M
107.58M
Chemicals
Miscellaneous Chemical Products
Link
United States
WASHINGTON